We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cutaneous Leishmaniasis Successfully Treated with Simple New Therapy

By LabMedica International staff writers
Posted on 09 Dec 2014
Print article
Image: Cutaneous leishmaniasis facial lesion, prior to initiation of successful treatment with daylight-activated photodynamic therapy (DA-PDT) (Photo courtesy of Enk CD et al. 2014, and the British Journal of Dermatology).
Image: Cutaneous leishmaniasis facial lesion, prior to initiation of successful treatment with daylight-activated photodynamic therapy (DA-PDT) (Photo courtesy of Enk CD et al. 2014, and the British Journal of Dermatology).
A new study has established an initial proof-of-concept that a daylight-activated (DA) form of photodynamic therapy (PDT) constitutes a simple and effective treatment for many cases of cutaneous leishmaniasis (CL). The novel, low-cost method is highly accessible, also for patients in rural and other areas with enough sunlight and lacking the technological infrastructure needed for conventional PDT.

A team of researchers from the Hadassah Medical Center & University Hospital (Jerusalem, Israel) and the Hebrew University Hadassah Medical School (Jerusalem, Israel), led by Claes Enk, MD, PhD, conducted the study with 31 patients that had been diagnosed with CL, with nonulcerated papulonodular lesions located on anatomical regions easily exposable to daylight: 11 patients with Leishmania major and 20 with L. tropica.

The patients were divided into two treatment groups: 14 underwent treatment in the hospital garden under professional supervision and 17 underwent self-administered treatment at home. Lesions were treated, at weekly intervals, by application of a thick layer of 16% methyl-aminolevulinate (MetvixR) and 30 minutes occlusion, followed by exposure to daylight for 2.5 hours. A limited number of control lesions were either treated with cryotherapy (painful, and required multiple liquid-nitrogen applications by healthcare professionals at the hospital) or left untreated. Lesions were monitored using clinical, microbiological, and molecular clearance as outcome measures.

Conventional PDT is time consuming, painful, and expensive, employing an artificial light source requiring healthcare professional use of equipment only available at specialized treatment centers. DA-PDT not only abolishes the need for an artificial light source instrument, but is relatively painless and in this study was also found to enable patients to very effectively self-administer the treatment at home with no professional assistance. The overall cure rate for hospital-based and self-administered DA-PDT was 88.9% (Intention-to-Treat cure rate 77.4%), for the hospital-based treatment group alone 85.7%, and for the self-administered treatment group 92.3%. All the L. major infected patients responded to treatments, whereas 3 of the L. tropica infected patients failed to respond to DA-PDT (L. tropica lesions are known to be generally less benign and more refractory to treatment).

The authors noted that though only a randomized controlled trial can determine the true efficacy of DA-PDT, the present study serves as proof-of concept of a novel self-administered, relatively painless PDT regimen for treatment of CL. Future studies are also needed to optimize the DA-PDT treatment protocol in terms of light doses, treatment frequencies, and penetration of the photosensitizer in larger and in ulcerated lesions. In addition, the use of alternative photosensitizers with better anti-leishmanial activity should be explored, especially for L. tropica infections.

The study, by Enk CD et al., was published in the British Journal of Dermatology, November 1, 2014, online ahead of print.

Related Links:

Hadassah Medical Center & University Hospitals
Hebrew University Hadassah Medical School


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Liquid Based Cytology Production Machine
LBP-4032
New
Silver Member
Oncology Molecular Diagnostic Test
BCR-ABL Dx ELITe MGB Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.